Search
Septerna Inc
SEPNAdd to Watchlist
34.450USD
-0.730-2.08%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.55BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Septerna Inc is 8.44, ranking 125 out of 385 in the Biotechnology & Medical Research industry. The average price target is 29.00, with a high of 34.00 and a low of 25.00.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
45.875
Target Price
+33.16%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Septerna Inc
SEPN
10
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Septerna Inc's expected revenue for the next quarter?
Septerna Inc's expected revenue is 15.71M.
What is Septerna Inc's price target?
Analysts forecast that Septerna Inc's price target is USD 29.00, with the highest forecast at USD 34.00 and the lowest forecast at USD 25.00.
How have Septerna IncSEPN's recent earnings per share performed?
The market expectation was USD -0.19, while Septerna IncSEPN's earnings per share (EPS) for the previous quarter was USD -0.24. EPS for the next quarter is expected at USD -0.47.
What is the analyst rating for Septerna Inc?
Based on the ratings of Septerna Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.